Psychometric and Clinimetric Validity of the Modified 25-Item Sino-Nasal Outcome Test

Abstract

Background

Productivity losses are a significant part of the disease burden associated with rhinosinusitis, but existing measures of disease-specific quality of life exclude explicit assessment of the impact of the disease on productivity.

Objective

The objective of this study was to evaluate the clinimetric and psychometric validity of the 25-item Sino-Nasal Outcome Test (SNOT-25), a modified version of the SNOT-22.

Methods

This was a prospective cohort study conducted at an academic medical center. Participants included adult patients with rhinosinusitis who presented for routine visits to the Washington University in St. Louis School of Medicine otolaryngology clinic between August 2016 and March 2017.

Results

The SNOT-25 was created with the addition of three productivity-specific items to the SNOT-22 instrument. A total of 120 rhinosinusitis patients completed all baseline measurements and 94 (78.3%) completed 3-month follow-up. The Cronbach’s α was 0.83, indicating high internal consistency. Rhinosinusitis patients had on average a 24-point higher baseline SNOT-25 score (95% confidence interval [CI]: 13–35) as compared to healthy controls indicating good discriminative validity. There was high correlation between SNOT-25 scores at 3 months and 3.5 months (r = .81; 95% CI, 0.73–0.87) confirming strong test–retest reliability. SNOT-25 had a strong correlation with the overall score of the Nasal Obstruction Symptom Evaluation instrument (r = .55; 95% CI, 0.42–0.65), and among Short Form-36 subscales, the strongest correlations existed between SNOT-25 and the fatigue scale (r = −.522; 95% CI, −0.63 to −0.39). Exploratory factor analysis revealed that the 3 new questions of SNOT-25 loaded together with reduction in productivity and concentration items on a new “productivity” factor.

Conclusion

The SNOT-25 is a valid instrument that can be used to assess rhinosinusitis disease burden including the impact on productivity and may be a better predictor of treatment decisions and outcomes.

Keywords

rhinosinusitis 25-item Sino-Nasal Outcome Test productivity absenteeism disease burden quality of life psychometric validity clinimetric validity presenteeism sino-nasal

Get full access to this article

View all access options for this article.

References

Villarroel MA, Blackwell DL. QuickStats: Age-adjusted percentages of adults aged ≥ 18 years who were told in the past 12 months by a doctor or health professional that they had sinusitis, by sex, race, and hispanic origin – National Health Interview Survey, 2017. MMWR Morb. Mortal. Wkly. Rep. 2019;68:361.

Bhattacharyya

Contemporary assessment of the disease burden of sinusitis.

Am J Rhinol Allergy. 2009; 23(4):392–395.

Soler

Wittenberg

Schlosser

Mace

Smith

TL.

Health state utility values in patients undergoing endoscopic sinus surgery.

Laryngoscope. 2011; 121(12):2672–2678.

Zhang

Bansback

Anis

AH.

Measuring and valuing productivity loss due to poor health: a critical review.

Soc Sci Med. 2011; 72(2):185–192.

Stankiewicz

Tami

Truitt

, et al. Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulum. Int Forum Allergy Rhinol. 2011; 1(1):38–45.

Rudmik

Smith

Schlosser

Hwang

Mace

Soler

ZM.

Productivity costs in patients with refractory chronic rhinosinusitis.

Laryngoscope. 2014; 124(9):2007–2012.

Rudmik

Smith

Mace

Schlosser

Hwang

Soler

ZM.

Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis.

Laryngoscope. 2016; 126(3):570–574.

Steele

Detwiller

Mace

Strong

Smith

Alt

JA.

Productivity outcomes following endoscopic sinus surgery for recurrent acute rhinosinusitis.

Laryngoscope. 2016; 126(5):1046–1053.

Bhattacharyya

The economic burden and symptom manifestations of chronic rhinosinusitis.

Am J Rhinol. 2003; 17(1):27–32.

10.

Schoenwetter

Dupclay

Jr Appajosyula

Botteman

Pashos

CL.

Economic impact and quality-of-life burden of allergic rhinitis.

Curr Med Res Opin. 2004; 20(3):305–317.

11.

Leung

Kern

Conley

Tan

Chandra

RK.

Establishing a threshold for surgery in recurrent acute rhinosinusitis: a productivity-based analysis.

Otolaryngol Head Neck Surg. 2012; 146(5):829–833.

12.

Rudmik

Soler

Smith

Mace

Schlosser

DeConde

AS.

Effect of continued medical therapy on productivity costs for refractory chronic rhinosinusitis.

JAMA Otolaryngol Head Neck Surg. 2015; 141(11):969–973.

13.

Chowdhury

Mace

Smith

Rudmik

What drives productivity loss in chronic rhinosinusitis? A SNOT-22 subdomain analysis.

Laryngoscope. 2018; 128(1):23–30.

14.

Hopkins

Gillett

Slack

Lund

Browne

JP.

Psychometric validity of the 22-item Sinonasal Outcome Test.

Clin Otolaryngol. 2009; 34(5):447–454.

15.

Piccirillo

Merritt

MGJ

Richards

ML.

Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20).

Otolaryngol Head Neck Surg. 2002; 126(1):41–47.

16.

Soler

Rudmik

Hwang

Mace

Schlosser

Smith

TL.

Patient-centered decision making in the treatment of chronic rhinosinusitis. Laryngoscope. 2013; 123(10):2341–2346.

17.

DeConde

Mace

Bodner

, et al. SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014; 4(12):972–979.

18.

Hopkins

Rudmik

Lund

VJ.

The predictive value of the preoperative Sinonasal Outcome Test-22 score in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis.

Laryngoscope. 2015; 125(8):1779–1784.

19.

Costa

Psaltis

Nayak

Hwang

PH.

Medical therapy vs surgery for recurrent acute rhinosinusitis.

Int Forum Allergy Rhinol. 2015; 5(8):667–673.

20.

Levy

Mace

Rudmik

Soler

Smith

TL.

Low 22-item sinonasal outcome test scores in chronic rhinosinusitis: Why do patients seek treatment?

Laryngoscope. 2017; 127(1):22–28.

21.

Feinstein

AR.

Clinimetrics. New Haven, CT: Yale University Press; 1987.

22.

Guyatt

Bombardier

Tugwell

PX.

Measuring disease-specific quality of life in clinical trials.

CMAJ. 1986; 134:889–895.

23.

Marx

Bombardier

Hogg-Johnson

Wright

JG.

Clinimetric and psychometric strategies for development of a health measurement scale.

J Clin Epidemiol. 1999; 52(2):105–111.

24.

Meltzer

Hamilos

Hadley

, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. 2004; 131(6 Suppl):S1–S62.

25.

Reilly

Zbrozek

Dukes

EM.

The validity and reproducibility of a work productivity and activity impairment instrument.

Pharmacoeconomics. 1993; 4(5):353–365.

26.

Weaver

Laizner

Evans

, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997; 20(10):835–843.

27.

Green

Porter

Bresnahan

Spertus

JA.

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

J Am Coll Cardiol. 2000; 35(5):1245–1255.

28.

Ware

Sherbourne

CD.

The MOS 36 Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992; 30:473–483.

29.

Stewart

Witsell

Smith

Weaver

Yueh

Hannley

MT.

Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale.

Otolaryngol Head Neck Surg. 2004; 130(2):157–63.

30.

Cronbach

LJ.

Coefficient alpha and the internal structure of tests.

Psychometrika. 1951; 16:297–334.

31.

Aday

LA.

Designing and Conducting Health Surveys: A Comprehensive Guide. San Francisco, CA: Jossey-Bass Publishers; 1996.

32.

Busner

Targum

SD.

The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007; 4(7):28–37.

33.

Feng

Wesely

Hoehle

, et al. A validated model for the 22-item Sino-Nasal Outcome Test subdomain structure in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017; 7(12):1140–1148.

34.

Hopkins

Patient reported outcome measures in rhinology. Rhinology. 2009; 47(1):10–17.

35.

Smith

Mace

Rudmik

Endoscopic sinus surgery compared to continued medical therapy for patients with refractory chronic rhinosinusitis.

Int Forum Allergy Rhinol. 2014; 4(10):823–827.

36.

Nathan

RA.

The burden of allergic rhinitis.

Allergy Asthma Proc. 2007; 28(1):3–9.